Meghmani Organics Ltd

Q1 FY27Fertilizers & Agrochemicals

Meghmani Organics Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹62

Market cap₹1.6K Cr

P/E25.0

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

0 of 3 strong

RevenueRank 3

MarginRank 3

CapexNo

Not discussed on this call: fundraise, order book.

The short version

Crop Protection Segment:** - Optimistic outlook for next 2-3 years with double-digit top-line growth. Meghmani Organics is optimistic about long-term growth, particularly in Crop Protection and Crop Nutrition segments, expecting healthy top-line and bottom-line growth over the next 2-3 years.

From Meghmani Organics Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3

**Crop Protection Segment:**
- Optimistic outlook for next 2-3 years with double-digit top-line growth.
- Volume decline of ~17% in the recent quarter due to macro factors but expected to recover.
- Focus on profitability alongside revenue growth; aiming for industry-average EBITDA margin of 15-17%.
- Healthy growth expected in both revenue and volumes over the medium term.
**Pigment Segment:**
- Revenue expected to remain stable around INR 500-600 crores annually.
- Capacity utilization likely to stay around 40-50%.
- EBITDA margin targeted near 10%, maintaining better profitability rather than pushing volume.
- No significant revenue growth planned due to market overcapacity and muted demand.
**Crop Nutrition (Nano Fertilizers):**
- Positive contribution currently with optimistic long-term growth.
- Expansion of product basket (Nano Urea, Nano DAP, Nano NPK, Nano Zinc).
- Revenue from this segment expected to cross INR 100 crores in the next 2-3 years.
Overall, management is confident of healthy top-line and bottom-line growth amid macroeconomic volatility.

Profitability & Margins

Meghmani Organics is optimistic about long-term growth, particularly in Crop Protection and Crop Nutrition segments, expecting healthy top-line and bottom-line growth over the next 2-3 years.
Crop Protection segment aims for double-digit revenue growth with EBITDA margins in the industry average range of 15%-17%.
Pigment segment revenue expected to remain stable (~INR500-600 crores) with targeted EBITDA margins around 10%, focusing on profitability rather than volume growth.
Nano fertilizer portfolio expansion (Nano DAP, Nano NPK, Nano Zinc) is expected to drive growth in Crop Nutrition segment with improving profitability.
Debt reduction and finance cost savings are expected due to continuous repayments and lack of heavy capex, supporting profit growth.
Despite near-term macroeconomic volatility and possible short-term challenges, management emphasized focus on bottom-line profitability and operational efficiencies.
Overall, expects growth in earnings and EPS driven by product mix optimization, cost controls, and market development.

See what Meghmani Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Meghmani Organics Limited does not plan to do heavy capex for the next one to two years. (Page 14)
Growth focus will be driven by investments in new registrations and product developments, especially in the Crop Protection and Crop Nutrition segments. (Pages 5, 6)
The company is expanding its Nano fertilizer product basket with new products like Nano DAP, Nano NPK, and Nano Zinc, indicating ongoing investment in product development. (Pages 3, 11)
No significant capex planned in the Pigment segment; focus is more on maintaining profitability rather than revenue growth through capacity expansion. (Pages 6, 7)
Amalgamation of two wholly owned subsidiaries is in process, expected to bring operational synergies and cost benefits rather than capital investment. (Page 9)

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

- Meghmani Organics Limited does not plan heavy capital expenditure (capex) in the next one to two years, which implies limited need for large-scale fundraising. - The company is focused on continuous debt repayment, with around INR130 crores repayment planned for the current year. - Debt reduction is a priority to lower finance costs; the company has already repaid approximately INR32 crores in Q1 FY27. - No mention of any new debt or equity fundraising plans was made during the call. - The management emphasized reducing debt gradually while growing top line and bottom line. - The ongoing amalgamation of wholly owned subsidiaries is expected to bring operational synergies but not additional fundraising. Overall, no current or near-term plans for new debt or equity fundraising have been indicated in the discussion.

See what Meghmani Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention the current or expected order book or pending orders for Meghmani Organics Limited as of Q1 FY27. However, the following related points are noted: - The company experienced softer demand across key markets resulting in subdued off-take during the quarter. - Healthy demand is seen in both Crop Protection and Pigment segments, with customers buying on a spot basis rather than building inventory. - For the Crop Nutrition segment, expansion of the product basket with new nano fertilizers has resulted in trial orders in different markets, showing encouraging results. - Overall, demand may continue to be influenced by macroeconomic uncertainties in the near term. - The company remains optimistic on long-term growth prospects and expects positive momentum to continue over coming quarters. No precise figures or outlook on order book or pending orders are disclosed in this transcript.

Meghmani Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹474 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Meghmani Organics Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsciences Ltd (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Gujarat State Fertilizers & Chemicals Ltd (Q1 FY27)
Profit after tax increased by 15% YoY in Q1 FY27, signaling positive growth trajectory. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's…
GSP Crop Science Ltd (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
Rallis India Ltd (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Meghmani Organics Ltd Q1 FY27 results?

What is Meghmani Organics Ltd share price analysis?

Meghmani Organics Ltd currently shows a below-average growth signal. The stock trades at a P/E of 25.0 with a market cap of ₹1,608 Cr. Investors should review the full earnings analysis for detailed insights.

Is Meghmani Organics Ltd planning capital expenditure?

Meghmani Organics Limited does not plan to do heavy capex for the next one to two years.

Keep Meghmani Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.